Acivicin induce filamentous growth of Saccharomyces cerevisiae.
Miyake T, Sammoto H, Ono B.
Biosci Biotechnol Biochem · journal article · DOI 10.1271/bbb.67.2283 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för acivicin. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
13 träffarAcivicin induces apoptosis independently of gamma-glutamyltranspeptidase activity.
Aberkane H, Frank P, Galteau MM, Wellman M.
Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1006/bbrc.2001.5297A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
Hidalgo M, Rodriguez G, Kuhn JG, Brown T, Weiss G, MacGovren JP, Von Hoff DD, Rowinsky EK.
Clin Cancer Res · clinical trial; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; clinical trial, phase i; journal articleIncreased activation of 2',3'-dideoxycytidine by acivicin.
Agarwal RP.
Biochem Biophys Res Commun · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1006/bbrc.1994.2104Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
Mukherjee T, Roy K, Bhaduri A.
Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1016/0006-291x(90)92109-dPhase I-II trial of acivicin in adult acute leukemia.
Powell BL, Craig JB, Capizzi RL, Richards F.
Invest New Drugs · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1007/bf00170778Interspecies comparison of acivicin pharmacokinetics.
McGovren JP, Williams MG, Stewart JC.
Drug Metab Dispos · comparative study; journal article · DOI 10.1016/s0090-9556(25)06895-3Acivicin reduces tumor growth during total parenteral nutrition (TPN).
Chance WT, Cao L, Nelson JL, Foley-Nelson T, Fischer JE.
Surgery · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal articleAcivicin (AT 125, U 42126): isolation and structure of an alkali-induced contaminant.
Martin DG, Mizsak SA, Nielsen JW.
J Antibiot (Tokyo) · research support, non-u.s. gov't; journal article · DOI 10.7164/antibiotics.39.603Acivicin in 1985.
Earhart RH, Neil GL.
Adv Enzyme Regul · review; journal article · DOI 10.1016/0065-2571(85)90076-7Biochemical pharmacology of acivicin in rat hepatoma cells.
Lui MS, Kizaki H, Weber G.
Biochem Pharmacol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/0006-2952(82)90628-1Acivicin. An antitumor antibiotic.
Poster DS, Bruno S, Penta J, Neil GL, McGovren JP.
Cancer Clin Trials · review; journal articleThe inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
Allen L, Meck R, Yunis A.
Res Commun Chem Pathol Pharmacol · research support, u.s. gov't, p.h.s.; journal article